C4 Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

C4 Therapeutics (NASDAQ: CCCC) announced that company management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York.

Rhea-AI Summary

C4 Therapeutics (NASDAQ: CCCC) announced that company management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 in New York.

The fireside chat is scheduled for Wednesday, February 11, 2026 at 11:30 AM ET. A live webcast will be available on the company’s Investors website, with an archived replay accessible for approximately 90 days.

Argus Feb 4 session

-5.97% close to close Open Argus

Details

News Market Reaction – CCCC

On Feb 4, the day this news came out, CCCC closed 5.97% below the previous close.

Data tracked by StockTitan Argus for the Feb 4 session.

Market Context

On Feb 4, the day this news came out, the stock closed 6.0% below the previous close. A negative rea...

Analysis

On Feb 4, the day this news came out, the stock closed 6.0% below the previous close. A negative reaction despite routine conference participation would contrast with the generally mild positive moves seen after recent corporate and clinical updates. With the stock at 2.01, below the 2.13 200-day MA and far under the 3.72 52-week high, sentiment had already been cautious. The presence of a $400,000,000 S-3 shelf could add overhang if investors anticipate further capital raises on top of prior offerings.

Key Figures

Summit dates: February 11–12, 2026 Fireside chat date: February 11, 2026 Fireside chat time: 11:30 AM ET +1 more

Summit dates

February 11–12, 2026

Guggenheim Emerging Outlook: Biotech Summit 2026

Fireside chat date

February 11, 2026

Scheduled C4 Therapeutics fireside chat

Fireside chat time

11:30 AM ET

Scheduled presentation time at Guggenheim summit

Webcast replay window

90 days

Archived webcast availability following the event

Historical Context

5 past events · Latest: Jan 26

5 events

1. Jan 26

   Inducement option grant

   24h Move

   +3.4%

   Single-employee stock option inducement grant under Nasdaq Rule 5635(c)(4).

2. Jan 14

   Program milestones update

   24h Move

   +0.9%

   Outlined cemsidomide milestones, Phase 2/1b plans, and cash runway to 2028.

3. Nov 25

   Conference participation

   24h Move

   +0.8%

   Announced fireside chat at 8th Annual Evercore Healthcare Conference.

4. Nov 06

   Q3 2025 earnings

   24h Move

   +0.4%

   Reported Q3 2025 financials, $125M equity raise, and positive cemsidomide data.

5. Oct 16

   Underwritten equity offering

   24h Move

   +11.7%

   $125M offering with shares, pre-funded and other warrants at set package prices.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WATERTOWN, Mass., Feb. 04, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today announced that C4T management will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 taking place from February 11 – 12, 2026 in New York, NY.

Fireside Chat Details:
Date: Wednesday, February 11, 2026
Time: 11:30 AM ET

A live webcast will be available on the Investors section of the company’s website at www.c4therapeutics.com. An archived replay of the webcast will be available for approximately 90 days following the event.

About C4 Therapeutics
C4 Therapeutics (C4T) (Nasdaq: CCCC) is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives. C4T is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO^® platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. C4T’s degrader medicines are designed to harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, drug undruggable targets and improve patient outcomes. For more information, please visit www.c4therapeutics.com.

Contacts:
Investors:
Courtney Solberg
Associate Director, Investor Relations
CSolberg@c4therapeutics.com

Media:
Loraine Spreen
Senior Director, Corporate Communications & Patient Advocacy
LSpreen@c4therapeutics.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is C4 Therapeutics (CCCC) presenting at the Guggenheim Emerging Outlook: Biotech Summit 2026?

C4 Therapeutics will present on February 11, 2026 at 11:30 AM ET as part of a fireside chat. According to the company, management will participate in the session during the February 11–12, 2026 summit in New York.

How can investors watch the C4 Therapeutics (CCCC) fireside chat webcast on February 11, 2026?

Investors can watch a live webcast on the company’s Investors webpage at www.c4therapeutics.com. According to the company, the live stream will be available at the scheduled time and an archived replay will be posted for about 90 days.

How long will the C4 Therapeutics (CCCC) webcast replay be available after the Guggenheim summit?

The archived replay will be available for approximately 90 days after the event. According to the company, viewers can access the replay on the Investors section of the company website following the February 11 fireside chat.

Will C4 Therapeutics (CCCC) management discuss targeted protein degradation at the Guggenheim summit?

Management will participate in a fireside chat where company focus and progress may be discussed. According to the company, C4 Therapeutics is dedicated to advancing targeted protein degradation science, which is central to its clinical-stage work.

Where and when is the Guggenheim Emerging Outlook: Biotech Summit 2026 where C4 Therapeutics (CCCC) will appear?

The summit takes place in New York from February 11–12, 2026, and C4 Therapeutics appears on February 11. According to the company, the fireside chat is scheduled for 11:30 AM ET on February 11, 2026.